HORMONAL INTRAUTERINE SYSTEM: ISSUES OF ITS ACCEPTABILITY AND SAFETY
- Авторлар: IVANOVA E.V1, SASUNOVA R.A1, LETUNOVSKAYA A.B1, PRILEPSKAYA V.N1, MEZHEVITINOVA E.A1, TAGIYEVA A.V1
-
Мекемелер:
- Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Шығарылым: № 4 (2011)
- Беттер: 140-144
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246598
- ID: 246598
Дәйексөз келтіру
Аннотация
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
E. IVANOVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: elena_999@mail.ru
R. SASUNOVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
A. LETUNOVSKAYA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
V. PRILEPSKAYA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
E. MEZHEVITINOVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
A. TAGIYEVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Әдебиет тізімі
- Вихляева Е.М., Николаева Е.И. Основные детерминанты репродуктивного поведения женщин: роды и индуцированный аборт // Планирование семьи. - 2001. -№ 1. - С. 15-18.
- Кукес В.Г., Сычев Д.А., Бруслик Т. и др. Изучение транспортеров лекарственных средств как новая возможность персонализации фармакотерапии // Врач. - 2007. -№ 5. - С. 2-5.
- Медицинские критерии приемлемости применения средств контрацепции. - 3-е изд. - Женева: ВОЗ, 2007.
- Медицинские критерии приемлемости применения средств контрацепции.- 4-е изд. - Женева: ВОЗ, 2009.
- Прилепская В. Н., Острейкова Л.И. Гормональная внутриматочная левоноргестрел-рилизинг-система «Мирена» // Гинекология. - 2006. - Т. 8, № 2. -С. 38-43.
- Руководство по контрацепции / Под ред. В.Н. Прилепской. - М.: МЕДпресс-информ, 2006.
- Савельева И.С. Медикаментозный аборт // Вопр. гин., акуш. и перинатол. - 2005. - Т. 4, № 2. - С. 1-4.
- Backman T., Huhtala S., Luoto R. et al. Advance information improves user satisfaction with the levonorgestrel intrauterine system // Obstet. and Gynecol. - 2002. - Vol. 99, № 4. -P. 608-613.
- Gardner F.J., Konje J.C., Abrams K.R. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial // Lancet. — 2000. — Vol. 356, № 9243. — P. 1711—1717.
- Grigorieva V.,Chen-Mok M., Tarasova M., Mikhailov A. Use of levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas // Fertil. and Steril. — 2003. — Vol. 79, № 5. — P. 1194—1198.
- Hurskainen R., Teperi J., Rissanen P. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up // J.A.M.A. — 2004. — Vol. 291, № 12. — P. 1456—1463.
- Jensen J.T. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: An overview // Obstet. Gynecol. Surv. — 2005. — Vol. 60, № 9. — P. 604—612.
- Kingman C.E., Kadir R.A., Lee C.A., Economides D.L. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders // Br. J Obstet.Gynaecol. — 2004. — Vol. 111, № 12. — P. 1425—1428.
- Pakarinen P., Luukkainen T. Five years’ experience with a small intracervical/intrauterine levonorgestrel-releasing device // Contraception. — 2005. — Vol. 72, № 5. — P. 342—345.
- Pakarinen P., Toivonen J., Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years’ follow-up // Contraception. — 2003. — Vol. 68, № 1. — P. 31—34.
- Rauramo I., Elo L., Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection // Obstet. and Gynecol. — 2004. — Vol. 104, № 6. — P. 1314—1321.
- Say R., Mansour D. Contraceptive choice for young people // J. Fam. Plann. Reprod. Hlth Care. — 2009. — Vol. 35, № 2. — P. 81—85.
- Templeman C.L., Cook V., Goldsmith L.J. et al. Postpartum contraceptive use among adolescent mothers // Obstet. and Gynecol. — 2000. — Vol. 95, № 5. — P. 770—776.
- Van Wouwe J.P., Lanting C.I., van Dommelen P. et al. Breastfeeding duration related to practised contraception in the Netherlands // Acta Paediatr. — 2009. — Vol. 98, № 1. — P. 86—90.
- Xuan B.T., Wiebren A.A., Tjalma M.D. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients // Fertil. and Steril. — 2008. — Vol. 90, № 1. — P. 17—22.
Қосымша файлдар
![](/img/style/loading.gif)